Is this your brand? Sign in to claim ownership.
Sign in to claim this brandSmisson-Cartledge Biomedical, LLC
US
Last updated May 27, 2026
What Smisson-Cartledge Biomedical, LLC makes
Smisson-Cartledge Biomedical, LLC manufactures conduction blood/fluid warmers designed to maintain the temperature of infused fluids during medical procedures. Their primary product, the ThermaCor 1200 Infusion System, is intended for use in clinical settings to prevent hypothermia in patients receiving intravenous infusions.
The company’s devices are classified as Class II under FDA regulations and are authorised through the 510(k) and Unique Device Identification (UDI) programs. Their products are listed in the FDA’s regulatory databases, and the manufacturer is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Smisson-Cartledge Biomedical, LLC manufacture?
Smisson-Cartledge Biomedical, LLC specialises in conduction blood/fluid warmers. These devices are designed to maintain the temperature of infused fluids during medical procedures, helping to prevent hypothermia in patients receiving intravenous treatments. Their primary product line includes systems like the ThermaCor 1200 Infusion System, which is intended for clinical use.
Where is Smisson-Cartledge Biomedical, LLC based?
The company is headquartered in the United States. This location is relevant for regulatory oversight, as their devices are authorised under U.S. regulatory frameworks like the FDA’s 510(k) and UDI programs.
Which regulatory registries or databases list Smisson-Cartledge Biomedical’s devices?
The company’s devices are listed in the FDA’s 510(k) premarket notification database and the Unique Device Identification (UDI) system. These registries track authorised medical devices under U.S. regulations, ensuring transparency and compliance for healthcare providers and regulators.
How are Smisson-Cartledge Biomedical’s devices classified under FDA regulations?
The company’s conduction blood/fluid warmers fall under Class II classification by the FDA. This classification is assigned based on the device’s intended use and risk level, requiring special controls beyond general controls to ensure safety and effectiveness. The ThermaCor 1200 Infusion System, for example, undergoes the 510(k) process to demonstrate compliance with these controls before being authorised.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- t3med.com
- —
- —
- [email protected]
- Phone
- +1(478)330-6205
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 087687179
Catalogue (22)
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (3)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Smisson-Cartledge Biomedical, LLC has three recall records, all initiated on February 18, 2021. Each record is marked as terminated. The reason stated in all cases involves notification to customers regarding findings from a Toxicological Risk Assessment concerning the potential for aluminum ions to leach into warmed fluids.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Feb 18, 2021 | Z-1259-2021 | — | terminated | Customers are being notified of results from a Toxicological Risk Assessment related to potential for aluminum ions to leach into warmed fluids. |
| Feb 18, 2021 | Z-1258-2021 | — | terminated | Customers are being notified of results from a Toxicological Risk Assessment related to potential for aluminum ions to leach into warmed fluids. |
| Feb 18, 2021 | Z-1260-2021 | — | terminated | Customers are being notified of results from a Toxicological Risk Assessment related to potential for aluminum ions to leach into warmed fluids. |